Klotho Neurosciences, Inc.
KLTO
$1.54
$0.042.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -232.44% | -1,534.23% | -1,953.71% | -70.80% | -289.57% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 298.57% | 914.20% | 1,811.80% | -- | -- |
| Change in Net Operating Assets | -228.14% | 1,044.07% | -140.90% | -408.08% | 3,322.64% |
| Cash from Operations | -6,962.27% | -373.28% | -6,061.11% | -776.71% | 86.41% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 100.00% | 100.00% | -1,135.00% |
| Cash from Investing | -- | -100.00% | 100.00% | 100.00% | -1,135.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,074.80% | 857.00% | -- | -- | -30.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,602.03% | 1,728.57% | -1,974.15% | 816.30% | -62.23% |